• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Bezafibrate Partially Rescues Mitochondrial Dysfunction in Cellular and Mouse Models

by
November 17, 2026
in Health
Reading Time: 3 mins read
0
Bezafibrate Partially Rescues Mitochondrial Dysfunction in Cellular and Mouse Models

Bezafibrate Partially Rescues Mitochondrial Dysfunction in Cellular and Mouse Models

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In experimental laboratory models of mitochondrial complex I deficiency, the therapeutic compound bezafibrate partially alleviated mitochondrial dysfunction in cells and significantly mitigated disease symptoms in mice, according to an investigation published in the Orphanet Journal of Rare Diseases. The research examined pathological mechanisms underlying Leigh syndrome, a severe and devastating mitochondrial encephalopathy caused by impaired oxidative phosphorylation and consequent bioenergetic failure across affected physiological systems. Because the protein NDUFAF2 serves as a critical assembly factor for mitochondrial complex I, the investigators sought to determine whether NDUFAF2 deficiency contributes directly to fibroblast dysfunction and whether treatment with bezafibrate could ameliorate the associated pathological phenotypes.

The investigators utilized cultured L929 fibroblasts as an in vitro model. The research team generated a stable knockdown of the NDUFAF2 gene in these cells. This model allowed evaluation of the consequences of complex I assembly failure on cellular health and mitochondrial performance.

The stable knockdown of NDUFAF2 in L929 fibroblasts impaired cell viability, actively promoted cellular apoptosis, and caused marked mitochondrial dysfunction. However, subsequent treatment with bezafibrate partially rescued these abnormal cellular phenotypes. These in vitro findings demonstrated that bezafibrate partially rescued survival and mitochondrial abnormalities in the cells.

To determine whether the protective properties of bezafibrate extended beyond cell culture to an in vivo setting of pharmacological complex I inhibition, the researchers examined rotenone-treated mice. The researchers also examined rotenone-treated mice, a model of complex I inhibition, to test whether bezafibrate could mitigate disease symptoms in an intact organism.

Rotenone exposure successfully induced an experimental Leigh syndrome-like phenotype in the mice, which was characterized by systemic weight loss, decreased food and water intake, motor dysfunction, and significantly shortened overall survival. Therapeutic administration of bezafibrate significantly attenuated all of these pathological abnormalities, showing that the compound effectively mitigated physiological deteriorations and functional behavioral deficits provoked by chemical complex I inhibition in vivo.

Mechanistic analyses in brain tissue revealed that bezafibrate improved mitochondrial function in fibroblast-enriched clusters. The treatment also restored molecular features associated with mitochondrial complex I homeostasis and reshaped critical disease-associated pathways, particularly those governing neuroactive ligand-receptor interactions and receptor-mediated mitophagy. These changes demonstrated pathway-level remodeling within brain tissue following systemic administration.

Targeted validation supported the involvement of the MCHR1/CRHR2-cAMP axis and mitophagy-related remodeling in these therapeutic responses. The authors concluded that NDUFAF2-dependent mitochondrial homeostasis in fibroblasts represents an important and previously underappreciated contributor to Leigh syndrome-like pathology. Furthermore, they emphasized that bezafibrate possesses therapeutic potential in experimental models of complex I dysfunction, warranting future investigation in genetically defined disease models.

Subject of Research: Therapeutic evaluation of bezafibrate in cellular and animal models of mitochondrial complex I deficiency

Article Title: Bezafibrate partially rescues mitochondrial dysfunction in NDUFAF2-deficient cellular and rotenone-induced models of complex I impairment

Article References: Wang, D., Lai, P., Cheng, K., Yu, P., Jiang, X., Shen, T., Lou, W., & Li, X. (2026). Bezafibrate partially rescues mitochondrial dysfunction in NDUFAF2-deficient cellular and rotenone-induced models of complex I impairment. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/s13023-026-04689-5

Image Credits: AI Generated

DOI: 10.1186/s13023-026-04689-5

Keywords: Bezafibrate, NDUFAF2, Mitochondrial complex I, Leigh syndrome, Mitochondrial encephalopathy, L929 fibroblasts, Rotenone, Oxidative phosphorylation, Mitochondrial dysfunction, Cell viability, Apoptosis, Motor dysfunction, Receptor-mediated mitophagy, MCHR1, CRHR2, cAMP axis, Bioenergetic failure

News Source: Ophelia Keating. (November 17, 2026). Bezafibrate Partially Rescues Mitochondrial Dysfunction in Cellular and Mouse Models. Scienmag.

Tags: ApoptosisBezafibrateBioenergetic failurecAMP axiscell viabilityCRHR2L929 fibroblastsLeigh syndromeMCHR1mitochondrial complex IMitochondrial dysfunctionMitochondrial encephalopathymotor dysfunctionNDUFAF2oxidative phosphorylationReceptor-mediated mitophagyrotenone
Share12Tweet7Share2ShareShareShare1

Related Posts

Molecular findings refine targeted therapy decisions in vascular malformations, review reports

Molecular findings refine targeted therapy decisions in vascular malformations, review reports

November 17, 2026
Docosahexaenoyl-Taurine Fails to Lower Postprandial Triglycerides in Healthy Young Men

Docosahexaenoyl-Taurine Fails to Lower Postprandial Triglycerides in Healthy Young Men

November 17, 2026

Bacterial Endolysin Kgh3 Degrades Peptidoglycan to Disrupt Resistant Klebsiella Biofilms

November 17, 2026

Religious Health Fatalism Associated with Fewer Health-Promoting Behaviors in Older Adults

November 17, 2026

POPULAR NEWS

  • High Prevalence of Gender-Based Violence Follows Armed Conflict in Southern Tigray

    High Prevalence of Gender-Based Violence Follows Armed Conflict in Southern Tigray

    29 shares
    Share 12 Tweet 7
  • Air Pollutants Tied to Adverse Sleep Outcomes Amid Notable Evidence Uncertainty

    29 shares
    Share 12 Tweet 7
  • Network Analysis Identifies Core Positive Development Attributes in Rural Chinese Adolescents

    29 shares
    Share 12 Tweet 7
  • China Silver Economy Policies Show Good Overall Consistency but Uneven Regional Breadth

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

SENP7 Knockdown Reduces Sevoflurane-Induced Cognitive Impairment in Offspring Mice

Molecular findings refine targeted therapy decisions in vascular malformations, review reports

Caregiver Survey Reliably Identifies Minimally Verbal Youth Across Diverse Autism Cohort

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.